$SUPN

$41.92▲ +0.0% YTD

7 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

News

SUPN ▲ +0.0% - Supernus Pharmaceuticals, Inc.

CP $41.92▲ +0.0%Nov 2, 2026 · ThinkSabio Blog

$SUPN - Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader…

News

SUPN ▲ +1.7% - Supernus Pharmaceuticals, Inc.

CP $41.84▲ +1.7%Oct 29, 2026 · ThinkSabio Blog

$SUPN - Supernus Announces Third Quarter 2026 Financial Results…

News

SUPN ▲ +0.9% - Supernus Pharmaceuticals, Inc.

CP $41.31▲ +0.9%Oct 28, 2026 · ThinkSabio Blog

$SUPN - Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for ‘Ms. Represented’ Campaign…

News

SUPN ▲ +0.6% - Supernus Pharmaceuticals, Inc.

CP $38.05▲ +0.6%Oct 19, 2026 · ThinkSabio Blog

$SUPN - Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026…

News

SUPN ▲ +0.7% - Supernus Pharmaceuticals, Inc.

CP $44.03▲ +0.7%Sep 2, 2026 · ThinkSabio Blog

$SUPN - Supernus Pharmaceuticals to Participate in September Investor Conferences…

News

SUPN ▼ -0.1% - Supernus Pharmaceuticals, Inc.

CP $43.70▲ -0.1%Aug 31, 2026 · ThinkSabio Blog

$SUPN - Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD…

SEC 13D/G

SUPN - Supernus Pharmaceuticals, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$46.76▼ -5.42%Aug 6, 2026 · ThinkSabio Blog

$SUPN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #SUPN Supernus Pharmaceuticals, Inc. : $46.76 Sector: Healthcare…